Nosebleeds or Epistaxis
Resources to guide physicians in the management of epistaxis.
Related Resources
Complications from Office Sclerotherapy for Epistaxis Due to HHT (Osler-Weber-Rendu)
Scientific Literature – 2014International Forum of Allergy & Rhinology. Authors: John E. Hanks, David Hunter, George S. Goding Jr, and Holly C Boyer. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreEfficacy of a Topical Sesame/Rose Geranium Oil Compound in Patients with HHT Associated Epistaxis (Article)
Scientific Literature – 2013The Laryngoscope. Authors: Douglas D. Reh, Kevin Hur, and Christian A. Merlo. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
More
Nosebleed Treatment Options
Article – 201290% of HHT patients experience epistaxis (nose bleeding). However, the severity, frequency and duration vary from patient-to-patient and family member-to-family member. There is no one treatment that works for everyone. This chart was developed by Dr…
MoreThe Young’s Procedure for Severe Epistaxis from HHT
Scientific Literature – 2012American Journal of Rhinology & Allergy. Authors: Sara L. Richer, M.D., Urban W. Geisthoff, M.D. and Urban W. Geisthoff. Department of Otorhinolaryngology, Hospitals of the City of Cologne, Cologne, Germany See all articles by this author Search Goog…
MoreTreatment of HHT Submucosal and Topical Bevacizumab Therapy
Scientific Literature – 2012Laryngoscope. Authors: Tom T. Karnezis and Terence M. Davidson. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreIntravenous and Topical Intranasal Bevacizumab (Avastin) in HHT
Scientific Literature – 2011American Journal of Otolaryngology. Authors: Brian T. Brinkerhoff, Nicholas W. Choong, Jonathan S. Treisman, and David M. Poetker. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreLong-Term Therapy with Bevacizumab in HHT
Scientific Literature – 2011The New England Journal of Medicine. Authors: Brian T. Brinkerhoff, David M. Poetker, and Nicholas W. Choong. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreAn Epistaxis Severity Score for HHT
Scientific Literature – 2010Laryngoscope. Authors: Jeffrey B. Hoag, Peter Terry, Sally Mitchell, Douglas Reh, and Christian A. Merlo. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreHereditary Hemorrhagic Telangiectasia / Avastin
Scientific Literature – 2009Laryngoscope. Authors: Terence M. Davidson, Scott E. Olitsky, and Julie L. Wei. This article can be purchased directly from the publisher. Click to view the article description and purchase options.
MoreWhat is an Arteriovenous Malformation (AVM)?
Scientific Literature – 2003American Stroke Association. Author: Randall T. Higashida, M.D. This article is available for public use and does not require purchase. Click to view the full article.
More
The Curacao Criteria: Consensus Diagnostic Criteria for HHT
Guidelines – 2000Author: Claire Shovlin, PhD.
MoreRelated News
A Monumental $128 Million Step Forward for HHT Research
Today is a monumental day for HHT. The new biotechnology company, Diagonal Therapeutics, officially launched and we wanted to share more about why this is news you simply can’t miss! In short, Diagona…
2024 National HHT Patient & Physician Conference
November 28, 2023
Help save lives this Giving Tuesday
November 23, 2023
Webinar – Pazopanib: A Groundbreaking Trial for HHT (Recording)
November 17, 2023
PAZ Clinical Trial Now Recruiting
October 6, 2023